Chemomab Therapeutics Ltd. American Depositary Share (CMMB)
Stock · NASDAQ · Health Care
$1.26as of 10/16/2026
Price chart
Active signals
CMMB Signal Track Record
How signals performed across all stocks →What CMMB's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | -5.9% | 37% | September 28, 2026 |
| Bollinger Band Breakout | 22 | -5.8% | 36% | August 26, 2026 |
| Bollinger Band Breakdown | 20 | -9.7% | 30% | September 23, 2026 |
| Any 20-session window (baseline) | -4.7% | 42% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CMMB
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating prima…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- www.chemomab.com/
Fundamentals
- 1-day range
- $1.26$1.35
- Market cap
- $12.95M
- P/E (trailing)
- —
- P/E (forward)
- -44.00
- EPS (trailing)
- $-0.01
- Dividend yield
- —
- Beta
- 0.82
- Avg. volume
- 103.5K
Forecasts
1 analyst ratings
Chemomab Therapeutics Ltd. American Depositary Share Competitors
Chosen by industry and closest market cap.
- CMMBChemomab Therapeutics Ltd. American Depositary Share$1.26▼ 1.94%Market cap $12.95MP/E —$1.05$3.5
- VTGNVistagen Therapeutics Inc. Common Stock$0.2▼ 4.76%Market cap $12.59MP/E —$0.198$5.14
- PBMPsyence Biomedical Ltd. Common Shares$4.22▼ 2.31%Market cap $13.31MP/E —$1.92$143.5
- GTBPGT Biopharma Inc. Common Stock$7.03▼ 4.48%Market cap $13.35MP/E —$4.91$34.25
- PHIOPhio Pharmaceuticals Corp. Common Stock$0.871▼ 5.94%Market cap $12.31MP/E —$0.8127$4.19
- BLRXBioLineRx Ltd. American Depositary Shares$2.01▼ 1.95%Market cap $12.14MP/E Infinity$1.1$2.3
- AEONAEON Biopharma Inc. Class A Common Stock$0.232▼ 4.53%Market cap $13.80MP/E —$0.1772$1.45
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CMMB Chemomab Therapeutics Ltd. American Depositary Share | $12.95M | — | $1.26 | ▼ 1.94% | $1.05$3.5 |
| VTGN Vistagen Therapeutics Inc. Common Stock | $12.59M | — | $0.2 | ▼ 4.76% | $0.198$5.14 |
| PBM Psyence Biomedical Ltd. Common Shares | $13.31M | — | $4.22 | ▼ 2.31% | $1.92$143.5 |
| GTBP GT Biopharma Inc. Common Stock | $13.35M | — | $7.03 | ▼ 4.48% | $4.91$34.25 |
| PHIO Phio Pharmaceuticals Corp. Common Stock | $12.31M | — | $0.871 | ▼ 5.94% | $0.8127$4.19 |
| BLRX BioLineRx Ltd. American Depositary Shares | $12.14M | Infinity | $2.01 | ▼ 1.95% | $1.1$2.3 |
| AEON AEON Biopharma Inc. Class A Common Stock | $13.80M | — | $0.232 | ▼ 4.53% | $0.1772$1.45 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Top movers analysis one hour before the close of the markets on 2026-09-30: top gainers and losers in today's session.ChartMill · 9/30/2026
- Chemomab Amends Merger Agreement Ahead Of U.S. Redomiciliation And Scipher CombinationBenzinga · 9/30/2026
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga · 9/30/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 9/28/2026
Insider Activity
Insider Actions →- Neil Harris Cohen · August 28, 2026 · Sale1.0K @ $2.8
- Neil Harris Cohen · August 27, 2026 · Sale1.3K @ $2.85
- George Adi Mor · May 29, 2026 · J18.8K
- George Adi Mor · May 29, 2026 · J31.7K
- George Adi Mor · May 29, 2026 · Buy4.9K @ $2.08
- George Adi Mor · May 29, 2026 · Buy4.9K @ $2.05
Institutional Ownership
March 31, 2026
- Total shares held
- 351.6K
- Total value held
- $551.9K
- Institutional holders
- 15
- Unknown80.0K
- Unknown64.2K
- Unknown61.7K
- Unknown51.8K
- Unknown18.6K
- Unknown18.4K
- Unknown14.6K
- Unknown13.5K
- Unknown8.4K
- Unknown8.2K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Chemomab Amends Merger Agreement for U.S. Redomiciliation
Chemomab has amended its merger agreement to facilitate a U.S. redomiciliation and combination with Scipher. This corporate restructuring is a significant development for the company's structure. The stock is currently trading near its 52-week low, reflecting the ongoing uncertainty surrounding these changes.
Chemomab Amends Merger Agreement for U.S. Redomiciliation. Chemomab has amended its merger agreement to facilitate a U.S. redomiciliation and combination with Scipher. This corporate restructuring is a significant development for the company's structure. The stock is currently trading near its 52-week low, reflecting the ongoing uncertainty surrounding these changes.